Author： Bailly Clément Leforestier Rodolphe Jamet Bastien Carlier Thomas Bourgeois Mickael Guérard François Touzeau Cyrille Moreau Philippe Chérel Michel Kraeber-Bodéré Françoise Bodet-Milin Caroline
Publisher： MDPI
E-ISSN： 1422-0067|18|2|445-445
ISSN： 1422-0067
Source： International Journal of Molecular Sciences, Vol.18, Iss.2, 2017-02, pp. : 445-445
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Role of Immunotherapy in Multiple Myeloma
By Kocoglu Mehmet Badros Ashraf
Pharmaceuticals, Vol. 9, Iss. 1, 2016-01 ,pp. :
Access to resources
Recommend
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. :
Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
By Merin Noah M. Kelly Kevin R.
Pharmaceuticals, Vol. 8, Iss. 1, 2014-12 ,pp. :